178 related articles for article (PubMed ID: 17113144)
1. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents.
Jeremy JY; Gadsdon P; Shukla N; Vijayan V; Wyatt M; Newby AC; Angelini GD
Biomaterials; 2007 Feb; 28(6):895-908. PubMed ID: 17113144
[TBL] [Abstract][Full Text] [Related]
2. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
[TBL] [Abstract][Full Text] [Related]
3. Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute.
Angelini GD; Jeremy JY
Biorheology; 2002; 39(3-4):491-9. PubMed ID: 12122271
[TBL] [Abstract][Full Text] [Related]
4. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
Wan S; Arifi AA; Chan MC; Yip JH; Ng CS; Chow LT; Yim AP; Jeremy JY
Eur J Cardiothorac Surg; 2006 May; 29(5):742-6; discussion 747. PubMed ID: 16581260
[TBL] [Abstract][Full Text] [Related]
5. A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.
Jeremy JY; Bulbulia R; Johnson JL; Gadsdon P; Vijayan V; Shukla N; Smith FC; Angelini GD
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1766-72. PubMed ID: 15173735
[TBL] [Abstract][Full Text] [Related]
6. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
7. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
Shukla N; Jeremy JY
Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
[TBL] [Abstract][Full Text] [Related]
9. Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Shukla N; Yim AP; Johnson JL; Angelini GD; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):494-500. PubMed ID: 17258588
[TBL] [Abstract][Full Text] [Related]
10. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
[TBL] [Abstract][Full Text] [Related]
11. Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery.
Baker AH; Yim AP; Wan S
Diabetes Obes Metab; 2006 Mar; 8(2):119-24. PubMed ID: 16448515
[TBL] [Abstract][Full Text] [Related]
12. Histological appearances of the long saphenous vein.
Milroy CM; Scott DJ; Beard JD; Horrocks M; Bradfield JW
J Pathol; 1989 Dec; 159(4):311-6. PubMed ID: 2614575
[TBL] [Abstract][Full Text] [Related]
13. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
Wan S; Shukla N; Angelini GD; Yim AP; Johnson JL; Jeremy JY
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1033-9. PubMed ID: 17903525
[TBL] [Abstract][Full Text] [Related]
15. Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting.
Izzat MB; Mehta D; Bryan AJ; Reeves B; Newby AC; Angelini GD
Circulation; 1996 Oct; 94(7):1741-5. PubMed ID: 8840869
[TBL] [Abstract][Full Text] [Related]
16. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
Collins P; Webb CM; Chong CF; Moat NE;
Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
[TBL] [Abstract][Full Text] [Related]
17. Flow patterns and preferred sites of intimal thickening in diameter-mismatched vein graft interpositions.
Sunamura M; Ishibashi H; Karino T
Surgery; 2007 Jun; 141(6):764-76. PubMed ID: 17560253
[TBL] [Abstract][Full Text] [Related]
18. Reinforcement of saphenous vein graft with ePTFE graft for axillocoronary bypass grafting.
Nagahama H; Fukushima Y; Hayase T; Yoshioka M; Onitsuka T
Ann Thorac Surg; 2005 Feb; 79(2):700-1. PubMed ID: 15680869
[TBL] [Abstract][Full Text] [Related]
19. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting.
Mehta D; George SJ; Jeremy JY; Izzat MB; Southgate KM; Bryan AJ; Newby AC; Angelini GD
Nat Med; 1998 Feb; 4(2):235-9. PubMed ID: 9461200
[TBL] [Abstract][Full Text] [Related]
20. Cardiac saphenous vein bypass graft disease.
Lau GT; Lowe HC; Kritharides L
Semin Vasc Med; 2004 May; 4(2):153-9. PubMed ID: 15478036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
